Clorox (NYSE:CLX) Price Target Cut to $139.00

Clorox (NYSE:CLX) had its target price lowered by equities research analysts at Evercore ISI from $140.00 to $139.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “underperform” rating on the stock. Evercore ISI’s target price suggests a potential downside of 14.90% from the company’s current price.

Several other research analysts have also recently issued reports on CLX. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. TD Cowen initiated coverage on Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $150.14.

Clorox Price Performance

Shares of CLX opened at $163.34 on Monday. The stock has a market cap of $20.28 billion, a P/E ratio of 84.63, a P/E/G ratio of 3.19 and a beta of 0.41. The business’s fifty day moving average is $158.14 and its 200 day moving average is $144.85. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. Clorox has a 12-month low of $114.68 and a 12-month high of $169.09.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Sell-side analysts anticipate that Clorox will post 6.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.51% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently bought and sold shares of CLX. Fiduciary Group LLC grew its position in Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after acquiring an additional 72 shares in the last quarter. GHP Investment Advisors Inc. boosted its holdings in shares of Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares in the last quarter. SPC Financial Inc. increased its position in shares of Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after purchasing an additional 75 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in shares of Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after buying an additional 75 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. lifted its position in Clorox by 5.1% in the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after buying an additional 83 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.